Agah Ramtin 4
4 · RenovoRx, Inc. · Filed Apr 16, 2025
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Agah Ramtin
DirectorChief Medical Officer
Transactions
- Award
Stock Option
2025-04-14+254,542→ 254,542 totalExercise: $0.84→ Common Stock (254,542 underlying)
Footnotes (1)
- [F1]On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted a non-qualified stock option to purchase up to 254,542 shares of the Issuer's common stock, with such option vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on April 14, 2035..